Virginia Commonwealth University
Richmond, Virginia, 23298, United States
NCT Number: NCT00110630
The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy combined with NicoDerm CQ for smoking cessation among female prisoners.
Looking for future studies?
Notify Me18 year–100 year
Female
Interventional
Phase 3
Richmond, Virginia, 23298, United States
This is a randomized controlled trial utilizing a wait-list control group to examine 10-week group therapy and nicotine replacement compared to wait-list for smoking cessation among female prisoners.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Drug Abuse (NIDA)
Nih
Smoking Treatment of Prisoners: Project "STOP"
Acronym: STOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT00136812
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT04768114
Behavior, Chemically-Induced Disorders
St Louis, Missouri, United States
View Trial DetailsNCT03626064
Behavior, Chemically-Induced Disorders
View Trial Details